Cargando…

Blockade of PD-L1 Enhances Cancer Immunotherapy by Regulating Dendritic Cell Maturation and Macrophage Polarization

The immuno-inhibitory checkpoint PD-L1, regulated by tumor cells and antigen-presenting cells (APCs), dampened the activation of T cells from the PD-1/PD-L1 axis. PD-L1-expressing APCs rather than tumor cells demonstrated the essential anti-tumor effects of anti-PD-L1 monotherapy in preclinical tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Nai-Yun, Chen, Yu-Li, Wu, Wen-Yih, Lin, Han-Wei, Chiang, Ying-Cheng, Chang, Chi-Fang, Tai, Yi-Jou, Hsu, Heng-Cheng, Chen, Chi-An, Sun, Wei-Zen, Cheng, Wen-Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769724/ https://www.ncbi.nlm.nih.gov/pubmed/31546897 http://dx.doi.org/10.3390/cancers11091400

Ejemplares similares

mTOR Inhibitors Can Enhance the Anti-Tumor Effects of DNA Vaccines through Modulating Dendritic Cell Function in the Tumor Microenvironment
por: Chen, Yu-Li, et al.
Publicado: (2019)

Impact of Adjuvant Modalities on Survival in Patients with Advanced Stage Endometrial Carcinoma: A Retrospective Analysis from a Tertiary Medical Center
por: Tai, Yi-Jou, et al.
Publicado: (2019)

Factors predicting parametrial invasion in patients with early-stage cervical carcinomas
por: Hsu, Heng-Cheng, et al.
Publicado: (2018)

BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19(high) B lymphocytes
por: Chen, Yu-Li, et al.
Publicado: (2019)

Bevacizumab Dose Affects the Severity of Adverse Events in Gynecologic Malignancies
por: Lee, Shu-Ping, et al.
Publicado: (2019)

Risk Factors of Hypersensitivity to Carboplatin in Patients with Gynecologic Malignancies
por: Tai, Yu-Hsiao, et al.
Publicado: (2017)

CD69 and SBK1 as potential predictors of responses to PD-1/PD-L1 blockade cancer immunotherapy in lung cancer and melanoma
por: Hu, Zhang-Wei, et al.
Publicado: (2022)

Outcome and prognostic factors of unexpected ovarian carcinomas
por: Cheng, Ching‐Yu, et al.
Publicado: (2022)

Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: A population‐based analysis
por: Lai, Yen‐Ling, et al.
Publicado: (2021)

Clinical management and risk reduction in women with low-grade squamous intraepithelial lesion cytology: A population-based cohort study
por: Tai, Yi-Jou, et al.
Publicado: (2017)

Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients
por: Lu, Hsiao-Yun, et al.
Publicado: (2020)

Risks of cervical intraepithelial neoplasia grade 3 or invasive cancers in ASCUS women with different management: a population-based cohort study
por: Tai, Yi-Jou, et al.
Publicado: (2018)

Fusion Protein Vaccines Targeting Two Tumor Antigens Generate Synergistic Anti-Tumor Effects
por: Cheng, Wen-Fang, et al.
Publicado: (2013)

Application of PD-1 Blockade in Cancer Immunotherapy
por: Wu, Xiaomo, et al.
Publicado: (2019)

Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
por: Wu, Bogang, et al.
Publicado: (2018)

Dual inhibition of BTLA and PD-1 can enhance therapeutic efficacy of paclitaxel on intraperitoneally disseminated tumors
por: Sun, Wei-Zen, et al.
Publicado: (2023)

Low intratumor heterogeneity correlates with increased response to PD-1 blockade in renal cell carcinoma
por: Ran, Xia, et al.
Publicado: (2020)

Preoperative magnetic resonance imaging predicts clinicopathological parameters and stages of endometrial carcinomas
por: Wu, Chia‐Ying, et al.
Publicado: (2021)

A DNA Damage Response Gene Panel for Different Histologic Types of Epithelial Ovarian Carcinomas and Their Outcomes
por: Chiang, Ying-Cheng, et al.
Publicado: (2021)

Age-specific trend and birth cohort effect on different histologic types of uterine corpus cancers
por: Tai, Yi-Jou, et al.
Publicado: (2023)

Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma
por: Cheng, Daoan, et al.
Publicado: (2023)

Astragalus polysaccharides (PG2) Enhances the M1 Polarization of Macrophages, Functional Maturation of Dendritic Cells, and T Cell-Mediated Anticancer Immune Responses in Patients with Lung Cancer
por: Bamodu, Oluwaseun Adebayo, et al.
Publicado: (2019)

Trends in the Research Into Immune Checkpoint Blockade by Anti-PD1/PDL1 Antibodies in Cancer Immunotherapy: A Bibliometric Study
por: Sun, Yiting, et al.
Publicado: (2021)

Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells
por: Gao, Wen-Xiang, et al.
Publicado: (2017)

VPS35-deficiency results in an impaired AMPA receptor trafficking and decreased dendritic spine maturation
por: Tian, Yun, et al.
Publicado: (2015)

Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma
por: Chiang, Ying-Cheng, et al.
Publicado: (2015)

Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer
por: Huang, Kevin Chih-Yang, et al.
Publicado: (2020)

Outcome and Subsequent Pregnancy after Fertility-Sparing Surgery of Early-Stage Cervical Cancers
por: Lee, Chia-Yi, et al.
Publicado: (2020)

Adaptor protein Shc acts as an immune-regulator for the LPS-stimulated maturation of bone marrow-derived dendritic cells
por: Chen, Kuang-Den, et al.
Publicado: (2011)

Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors
por: Shen, Hung, et al.
Publicado: (2021)

Recent developments in PD-1/PD-L1 blockade research for gastroesophageal malignancies
por: Chen, Meng, et al.
Publicado: (2022)

Gene Expression Profiling of Dendritic Cells in Different Physiological Stages under Cordyceps sinensis Treatment
por: Li, Chia-Yang, et al.
Publicado: (2012)

An update on immunotherapy with PD-1 and PD-L1 blockade
por: Koh, Sung Ae
Publicado: (2021)

Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
por: Tsang, Yuk-Wah, et al.
Publicado: (2015)

Pain Perception Can Be Modulated by Mindfulness Training: A Resting-State fMRI Study
por: Su, I-Wen, et al.
Publicado: (2016)

Antimesothelioma Immunotherapy by CTLA-4 Blockade Depends on Active PD1-Based TWIST1 Vaccination
por: Tan, Zhiwu, et al.
Publicado: (2020)

The polarity protein Angiomotin p130 controls dendritic spine maturation
por: Wigerius, Michael, et al.
Publicado: (2018)

Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy
por: Ren, Daixi, et al.
Publicado: (2020)

Recent Advancements in the Mechanisms Underlying Resistance to PD-1/PD-L1 Blockade Immunotherapy
por: Yuan, Yu, et al.
Publicado: (2021)

Spatial Distribution and Predictive Significance of Dendritic Cells and Macrophages in Esophageal Cancer Treated With Combined Chemoradiotherapy and PD-1 Blockade
por: Ma, Xiaoxue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bbe02nlbh2tnmma7l29e6r1nen